🚨BREAKING: *preliminary* data show potential benefit of convalescent plasma containing #coronavirus antibodies (from recovered #COVID19 patients) for the treatment of critically ill patients.— Dr. Dena Grayson (@DrDenaGrayson) March 27, 2020
Same approach was used for H1N1 and Spanish Flu.
Larger study needed to confirm.🤞🏼 https://t.co/r5IZasRvUm
Friday, March 27, 2020
BREAKING: *preliminary* data show potential benefit of convalescent plasma containing #coronavirus antibodies (from recovered #COVID19 patients) for the treatment of critically ill patients. Same approach was used for H1N1 and Spanish Flu. Larger study needed to confirm
